About Us

Protheragen Release is part of Protheragen's broad business area, which is a global contract research organization (CRO) headquartered in New York, USA. Protheragen Release is focused on providing customers with quality fast release services, available in microneedle patches and freeze-dried flash release technologies.

The Protheragen Release platform has cutting-edge manufacturing equipment and technical means, bringing revolutionary innovative technology for drug dosage form development. Our microneedle technology uses a homemade 3D printer, which has an extremely high degree of freedom in precise design and can quickly fabricate precise and complex microneedles. Freeze-dried flash release technology is used to create products that break down or dissolve quickly in the mouth without water, which is of great significance for improving drug compliance and accelerating drug onset.

Protheragen Release is primarily aimed at drug developers. Of course, our technology is also applicable to the development of cosmetics, or the formulation research of food and nutraceuticals.

Large-scale platform for freeze-dried flash release preparations

Accurate microneedles fabricated by mold-free, patch-by-patch 3D printing

Customized services
Create formulations with your ideas